on 13 Aug 2024
Last Applicant/ Owned by
8 Connaught Place
Central
HK
Serial Number
97632833 filed on 14th Oct 2022
Registration Number
7470850 registered on 13th Aug 2024
Correspondent Address
Louise Arnott
Filing Basis
1. intent to use
Disclaimer
NO DATA
Drug discovery research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; product research and development in the field of biotechnology, molecular biology, pharmaceutics, oncology, immunology, biology and chemistry; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceutical drugs and product Read More
Drug discovery research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; product research and development in the field of biotechnology, molecular biology, pharmaceutics, oncology, immunology, biology and chemistry; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceutical drugs and product research and design relating thereto; artificial intelligence driven robotics drug discovery scientific laboratory services; design and development of computer hardware and software; Software as a service (SAAS) services featuring software for use in database management n the field of drug design and development; software development in the framework of software publishing; updating of computer software; Platform as a service (PAAS) featuring computer software platforms for use in database management in the field of drug design and development; development of computer platforms; computer system design; rental of computer software for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website-based indexes of information in the field of drug design and development for others using information technology services; computer programming; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; platform as a service (PaaS) featuring computer software platforms for use in database management for using artificial intelligence for automated machine learning in the field of drug design and development; research in the field of artificial intelligence; conversion of data or documents from physical to electronic media; conversion of computer programs and data, other than physical conversion; electronic data storage; computer programming service for data processing; providing medical and scientific research information; Providing a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; provision of scientific information in the fields of pharmaceutical research and development, drug discovery and medical and scientific research; computer software design; software as a service (SaaS) services featuring software for using artificial intelligence for automated machine learning in the field of drug design and development; platform as a service (PaaS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website based indexes of data and information for others using information technology; computer programming services; installation of computer software; installation, maintenance, and updating of computer software; installation of software using artificial intelligence for automated machine learning in the field of drug design and development; customizing computer software; custom design of computer software; developing customized software in the field of drug design and development
N/A
N/A
Computers, computer hardware and computer peripheral devices; downloadable mobile applications using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software using artificial intelligence for automated machine learning in the field of drug design and development; downloadable computer programs using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer programs using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded; data processing apparatus being data processors; Electronic card readers; data processing equipment, namely, scanners; Downloadable computer software using artificial intelligence for machine learning in the field of drug design and development; Downloadable data sets using artificial intelligence for automated machine learning in the field of drug design and development; Data sets using artificial intelligence for automated machine learning in the field of drug design and development recorded on computer media; downloadable and recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded, for automated machine learning in the field of drug design and development; data processing apparatus, namely, data processors for automated machine learning in the field of drug design and development
N/A
N/A
No 97632833
No Service Mark
No 216786-0001
No
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
13th Aug 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
13th Aug 2024 | REGISTERED-PRINCIPAL REGISTER |
28th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
28th May 2024 | PUBLISHED FOR OPPOSITION |
08th May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
09th Apr 2024 | CASE RETURNED TO EXAMINATION |
03rd Apr 2024 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
02th Apr 2024 | ASSIGNED TO PETITION STAFF |
19th Mar 2024 | NOTICE OF ALLOWANCE CANCELLED |
13th Mar 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |